One week has already passed since the MIRACUM Symposium took place. Not as planned in Freiburg, but virtually. Despite these circumstances, we can proudly say that it was a fantastic event. A big thank you to everyone that made this possible: the
We have currently more than 250 registrations for our MIRACUM Online Symposium and there are continuously new requests for participation. Therefore we have now managed (in addition to our Zoom web conference) to stream the Online Symposium also o
As part of the MII, the UKSH Campus Lübeck is cooperating with MIRACUM in an interdisciplinary project on molecular tumor boards. The aim is to develop standardized methods, quality management and knowledge databases for molecular interpretation
With immediate effect, all participants of the medical informatics initiative and their cooperation partners can obtain a free SNOMED CT license. It represents an important step for medical research. Thanks to SNOMED CT, different terms in medical
The MIRACUM Consortium has decided to hold its Annual Symposium as an Online Symposium in a shorter version than originally planned. We have organized two sessions with a lunch break in between. 27.03.2020 / 10.00 - 11.30 / Session 1:
Dear interested participants of the MIRACUM Symposium, In order to protect patients and employees, the Freiburg University Hospital board of directors has decided to cancel all public events at the Freiburg University Hospital until 5 April 2020.
21 interdisciplinar partners have joined forces in the polar_mi research project (Polypharmacy, drug-drug-interactions and risks) to improve drug therapy and enhance patient safety. The project started in February 2020 and is funded with 5,5 mill
Due to the current developments of the coronavirus COVID 19 in Germany we also discuss which actions to take for the MIRACUM symposium in Freiburg. However, we have already committed ourselves to the following decision: The MIRACUM symposium wil
Following the first NSG meeting of the year, the MII invited to a political evening on 13.02.2020. In a top-class panel discussion achievements of the first two years, remaining challenges and future goals were discussed in order to further advan
Clinicians in molecular tumor boards (MTB) are confronted with a growing amount of high-throughput sequencing data. Today, at German university hospitals, these data are usually handled in complex spreadsheets from which clinicians have to obtai